Key result
Modulating the neural pathways involved in glucose homeostasis via bioelectronic medicine presents emerging opportunities for the treatment of type 1 and type 2 diabetes.
Bioelectronic medicine targeting the nervous system's role in glucose homeostasis represents a potential future therapeutic pathway for diabetes management.
Answers are grounded in this paper and cite their sources.
CNS modulation may enable bioelectronic glucose control; leaves open translation to practice pending trials.
Diabetes is a disease caused by a breakdown in the glucose metabolic process resulting in abnormal blood glucose fluctuations. Traditionally, control has involved external insulin injection in response to elevated blood glucose to substitute the role of the beta cells in the pancreas which would otherwise perform this function in a healthy individual. The central nervous system (CNS), however, also plays a vital role in glucose homoeostasis through the control of pancreatic secretion and insulin sensitivity which could potentially be used as a pathway for enhancing glucose control. In this review, we present an overview of the brain regions, peripheral nerves and molecular mechanisms by which the CNS regulates glucose metabolism and the potential benefits of modulating them for diabetes management. Development of technologies to interface to the nervous system will soon become a reality through bioelectronic medicine and we present the emerging opportunities for the treatment of type 1 and type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Güemes et al. (2018) conducted a review in Diabetes. Bioelectronic medicine / Neuromodulation was evaluated. Modulating the neural pathways involved in glucose homeostasis via bioelectronic medicine presents emerging opportunities for the treatment of type 1 and type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: